Navigation Links
Alberta companies delivering new products to the health & medical marketplace
Date:12/4/2009

    Alberta Centre for Advanced Micro Nano Technology Products (ACAMP) hosts
    health & medical seminar

EDMONTON, Dec. 4 /PRNewswire/ - Today ACAMP hosted a health & medical seminar, explaining how technologies like nanotechnology, biomaterials and microfluidics can play a powerful role in the creation of innovative healthcare products that help promote health and improve the quality, cost and outcomes of patient care, while opening new markets for Alberta companies worldwide.

"Nanotechnology is a platform for innovation in health, and many other industries, and ACAMP offers both technical and business services to move those innovations into the marketplace," said Doug Horner, Minister of Alberta Advanced Education and Technology. "Our government helped to build an accomplished biomedical research community in Alberta, and our renewed innovation system will lead to more biomedical breakthroughs, like Acticoat's silver treated bandages."

"Alberta is well known for innovative conventional energy applications, similarly, substantial investments in the development of health and medical applications have made the province a world leader in a host of medical applications," said Ken Brizel, CEO of ACAMP. "Innovative new products and services for improving the quality of health care within the region and worldwide will expand Alberta's economy."

In addition to health and medical technology solutions, the seminar features discussions by venture capitalists on moving ideas from the laboratory to the marketplace and the various ways to secure investment for entrepreneurs and start-up companies. Future ACAMP seminars will cover MNT (Micro Nano Technologies) for the conventional energy, agriculture & forestry industries and clean technologies. For complete information on the programs go to www.acamp.ca for details.

ACAMP is a not for profit organization that provides specialized technical and business services. ACAMP clients have access to world-class equipment, facilities, expertise and a network of organizations to support the development and manufacturing of micro and nanotechnology based systems and advanced materials for applications worldwide. ACAMP's funding comes from Alberta Advanced Education & Technology, Western Economic Diversification Canada and Industry. Funding for the ACAMP seminar series is provided by the National Research Council's Industrial Research Assistance Program.

SOURCE ACAMP


'/>"/>
SOURCE ACAMP
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Enerkem Announces Construction Start on Advanced Energy Research Facility in Edmonton, Alberta
2. Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada
3. Enerkem GreenField Alberta Biofuels Awarded Permit to Build Worlds First Commercial Municipal Waste-to-Biofuels Facility
4. BioMS Medical to present at Alberta Economic Forum in Geneva
5. University of Alberta and NINT researchers make solar energy breakthrough
6. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
7. BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year
8. Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies
9. World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol
10. Four Michigan Companies Receive $200,000 From Ann Arbor SPARKs Microloan Program
11. New Program to Bring University of Florida Incubator Companies Millions in New Contracts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 27, 2017 A Europe-wide survey of institutes ... using animals in their research treat them with due care. The ... detailed analysis of the results indicates that there is a strong ... put into practice the principles of the 3Rs (Refine, Reduce, ... What are ...
(Date:2/27/2017)... REDWOOD CITY, Calif. , Feb. 27, 2017 ... specialty pharmaceutical company focused on the development and ... moderate-to-severe acute pain, announced today the U.S. Food ... New Drug Application (NDA) under section 505(b)(2) for ... for the treatment of patients with moderate-to-severe acute ...
(Date:2/27/2017)... HAMILTON, Bermuda , Feb. 27, 2017 /PRNewswire/ ... ) and SELLAS Life Sciences Group , ... immunotherapies, today announced that Advaxis has granted SELLAS ... agent using Advaxis, proprietary Lm -based antigen ... peptide antigen mixture (galinpepimut-S). Advaxis, ...
(Date:2/27/2017)... URBANDALE, Iowa (PRWEB) , ... February 27, 2017 , ... ... is following the advice of his grandfather, “Hire for attitude. Train for skill.” , ... State University star linebacker Jevohn Miller as a salesman. Zamzow is hoping to replicate ...
Breaking Biology Technology:
(Date:2/24/2017)... BARCELONA, Spain , Feb. 24, 2017  EyeLock LLC, ... will demonstrate its elite iris biometric solution on ... with X16 LTE at Mobile World Congress ... in Qualcomm,s Booth in Hall 3, Stand ... contains the Qualcomm Haven™ security platform—a combination ...
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):